Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MAC 2006 Launches Feature Icon Deneuve, Floral-Inspired Collections

This article was originally published in The Rose Sheet

Executive Summary

MAC first half 2006 launch program includes its third Beauty Icon collection and Dejarose cosmetics and fragrance, the Estee Lauder division said

You may also be interested in...



Estee Lauder Will Unload Stila As Part Of Portfolio Optimization Strategy

Estee Lauder's stila cosmetics collection is the first casualty of the firm's brand portfolio optimization effort, part of a larger strategy aimed at improving the company's bottom line. The firm announced plans to divest the makeup artist brand in its Oct. 26 first quarter earnings call

Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure

Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.

MADIT-CRT Data Support Expanded Cardiac Resynchronization Market

The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013550

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel